Research Papers

25 of 522 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative ba…
Fratoni AJ; Berry AV; Liu X; Chen X; Wu Y; Nicolau DP; Abdelraouf K.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
National point-prevalence survey of healthcare-associated infections and antimicrobial use: UK-PAS/UKHSA joint call to …
Channon-Wells S; Elmes J; Muller-Pebody B; McGarrity O; Chappell F; Drysdale SB; Ashiru-Oredope D; Patel S; Demirjian A.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
The native ABC-F proteins of Staphylococcus aureus do not contribute to intrinsic resistance against ribosome-targeting…
Galarion LH; Trigwell J; Mohamad M; Nakamoto JA; Clarke JE; Atkinson GC; O'Neill AJ.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenof…
Saborido-Alconchel A; Serna-Gallego A; Lopez-Cortes LE; Trujillo-Rodriguez M; Praena-Fernandez JM; Dominguez-Macias M; Lozano C; Muñoz-Muela E; Espinosa N; Roca-Oporto C; Sotomayor C; Herrero M; Gutierrez-Valencia A; Lopez-Cortes LF.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple…
Lombardi F; Sanfilippo A; Fabbiani M; Borghetti A; Ciccullo A; Tamburrini E; Di Giambenedetto S.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicill…
Barker CIS; Kipper K; Lonsdale DO; Wright K; Thompson G; Kim M; Turner MA; Johnston A; Sharland M; Standing JF.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators.
Renggli L; Plüss-Suard C; Gasser M; Sonderegger B; Kronenberg A.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms.
Alam F; Blackburn SA; Davis J; Massar K; Correia J; Tsai HJ; Blair JMA; Hall RA.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Data Funding Declared
Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study.
Skow M; Fossum GH; Høye S; Straand J; Brænd AM; Emilsson L.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German h…
Bender JK; Baufeld E; Becker K; Claus H; Dudakova A; Dörre A; Fila N; Fleige C; Hamprecht A; Hoffmann A; Hogardt M; Kaasch AJ; Kola A; Kriebel N; Layer-Nicolaou F; Marschal M; Molitor E; Mutters NT; Liese J; Nelkenbrecher C; Neumann B; Rohde H; Steinmann J; Sörensen M; Thelen P; Weig M; Zautner AE; Werner G.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting.
Pai Mangalore R; Peel TN; Udy AA; Peleg AY.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!
Korzilius JW; Gompelman M; Wezendonk GTJ; Jager NGL; Rovers CP; Brüggemann RJM; Wanten GJA.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infection…
Ando N; Mizushima D; Takano M; Mitobe M; Kobayashi K; Kubota H; Miyake H; Suzuki J; Sadamasu K; Aoki T; Watanabe K; Uemura H; Yanagawa Y; Gatanaga H; Oka S.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-…
Tsai D; Zam BB; Tongs C; Chiong F; Sajiv C; Pawar B; Ashok A; Cooper BP; Tong SYC; Janson S; Wallis SC; Roberts JA; Parker SL.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK.
Carter C; Hutchison A; Rudder S; Trotter E; Waters EV; Elumogo N; Langridge GC.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aerugino…
Abouelhassan Y; Gill CM; Nicolau DP.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recomm…
Stemler J; Mellinghoff SC; Khodamoradi Y; Sprute R; Classen AY; Zapke SE; Hoenigl M; Krause R; Schmidt-Hieber M; Heinz WJ; Klein M; Koehler P; Liss B; Koldehoff M; Buhl C; Penack O; Maschmeyer G; Schalk E; Lass-Flörl C; Karthaus M; Ruhnke M; Cornely OA; Teschner D.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Es…
Sojo-Dorado J; López-Hernández I; Hernández-Torres A; Retamar-Gentil P; Merino de Lucas E; Escolà-Vergé L; Bereciartua E; García-Vázquez E; Pintado V; Boix-Palop L; Natera-Kindelán C; Sorlí L; Borrell N; Amador-Prous C; Shaw E; Jover-Saenz A; Molina J; Martínez-Álvarez RM; Dueñas CJ; Calvo-Montes J; Lecuona M; Pomar V; Borreguero I; Palomo-Jiménez V; Docobo-Pérez F; Pascual Á; Rodríguez-Baño J.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
Mandelbrot L; Tubiana R; Frange P; Peytavin G; Le Chenadec J; Canestri A; Morlat P; Brunet-Cartier C; Sibiude J; Peretti D; Chambrin V; Chabrol A; Bui E; Simon-Toulza C; Marchand L; Paul C; Delmas S; Avettand-Fenoel V; Warszawski J; Monogest study group.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Implementation of WGS analysis of ESBL-producing Escherichia coli within EU AMR monitoring in livestock and meat.
Brouwer MSM; Zandbergen Van Essen A; Kant A; Rapallini M; Harders F; Bossers A; Wullings B; Wit B; Veldman KT.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at…
Sealey JE; Saunders R; Horspool T; Barrows MG; Avison MB.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.
Soriano A; Honore PM; Puerta-Alcalde P; Garcia-Vidal C; Pagotto A; Gonçalves-Bradley DC; Verweij PE.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria.
Dortet L; Niccolai C; Pfennigwerth N; Frisch S; Gonzalez C; Antonelli A; Giani T; Hoenings R; Gatermann S; Rossolini GM; Naas T.
J Antimicrob Chemother (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis.
Malin JJ; Weibel S; Gruell H; Kreuzberger N; Stegemann M; Skoetz N.
J Antimicrob Chemother (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infe…
Kong FYS; Kenyon C; Unemo M.
J Antimicrob Chemother (Unknown)
Published: 2023
2/6 Transparent
Funding Declared